These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6556004)

  • 1. Serious infections due to group G streptoccocci. Report of 15 cases with in vitro-in vivo correlations.
    Lam K; Bayer AS
    Am J Med; 1983 Oct; 75(4):561-70. PubMed ID: 6556004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group G streptococcal septicaemia: clinical observations and laboratory studies.
    Finch RG; Aveline A
    J Infect; 1984 Sep; 9(2):126-33. PubMed ID: 6501901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of Streptococcus bovis to six antibiotics.
    Klein RS; Milazzo JJ; Edberg SC
    Clin Ther; 1984; 6(4):518-23. PubMed ID: 6467280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group B streptococcal infective endocarditis.
    Backes RJ; Wilson WR; Geraci JE
    Arch Intern Med; 1985 Apr; 145(4):693-6. PubMed ID: 3885892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penicillin G-resistant viridans group streptococcal endocarditis and interpretation of the American Heart Association's Guidelines for the Treatment of Infective Endocarditis.
    Fujitani S; Rowlinson MC; George WL
    Clin Infect Dis; 2008 Apr; 46(7):1064-6. PubMed ID: 18444825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of group G streptococci to ten antimicrobial agents with broad gram-positive spectra.
    Bayer AS; Lam K
    Clin Ther; 1983; 5(4):391-7. PubMed ID: 6871922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of penicillin resistance on presentation and outcome of nonenterococcal streptococcal infective endocarditis.
    Hsu RB; Lin FY
    Cardiology; 2006; 105(4):234-9. PubMed ID: 16534200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-antibiotic therapy for streptococcal endocarditis.
    Karchmer AW; Moellering RC; Maki DG; Swartz MN
    JAMA; 1979 Apr; 241(17):1801-6. PubMed ID: 107335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G.
    Tissi L; von Hunolstein C; Mosci P; Campanelli C; Bistoni F; Orefici G
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1938-47. PubMed ID: 8540695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy.
    Levy CS; Kogulan P; Gill VJ; Croxton MB; Kane JG; Lucey DR
    Clin Infect Dis; 2001 Aug; 33(4):577-9. PubMed ID: 11462199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocarditis due to Streptococcus mitis with high-level resistance to penicillin and cefotaxime.
    Lonks JR; Dickinson BP; Runarsdottir V
    N Engl J Med; 1999 Oct; 341(16):1239. PubMed ID: 10523160
    [No Abstract]   [Full Text] [Related]  

  • 12. Infective endocarditis caused by Streptococcus bovis resistant to the lethal effect of penicillin G.
    Savitch CB; Barry AL; Hoeprich PD
    Arch Intern Med; 1978 Jun; 138(6):931-4. PubMed ID: 246729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of endocarditis caused by relatively resistant nonenterococcal streptococci: is penicillin enough?
    DiNubile MJ
    Rev Infect Dis; 1990; 12(1):112-7. PubMed ID: 2405464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.
    Durack DT; Pelletier LL; Petersdorf RG
    J Clin Invest; 1974 Mar; 53(3):829-33. PubMed ID: 4492776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.
    Watanakunakorn C; Glotzbecker C
    J Med Microbiol; 1977 Feb; 10(1):133-8. PubMed ID: 584243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial therapy of streptococcal endocarditis.
    Scheld WM
    Eur J Clin Microbiol; 1982 Oct; 1(5):263-6. PubMed ID: 7184766
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci.
    Shelburne SA; Greenberg SB; Aslam S; Tweardy DJ
    J Infect; 2007 Feb; 54(2):e99-101. PubMed ID: 16824611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillin-resistant Streptococcus constellatus as a cause of endocarditis.
    Levin RM; Pulliam L; Mondry C; Levy D; Hadley WK; Grossman M
    Am J Dis Child; 1982 Jan; 136(1):42-5. PubMed ID: 7055109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and antimicrobial therapy of infections caused by group G streptococci.
    Rolston KV; Chandrasekar PH; LeFrock JL
    Infection; 1985; 13(5):203-6. PubMed ID: 4066043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of bacterial endocarditis.
    Tumulty PA
    Geriatrics; 1967 Jun; 22(6):122-39. PubMed ID: 6024963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.